Patent
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharma market insights with critical patent analysis. Stay ahead of IP trends, litigation, and exclusivity strategies for competitive advantage.
Showing 1–10 of 10 articles
Quick answer
NovaPharmaNews Patent hub for FDA covers 10 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
FDA guidance on sharing potential NDA patent information: what changes now
Alembic Wins Tentative FDA Nod for First Generic Larotrectinib Capsules
Supreme Court sides with generic drug maker in icosapent ethyl patent case
Generic Drugmakers Gain Key Victory in ‘Skinny Label’ Patent Case
STAT Supreme Court backs generic drugmaker in 'skinny labeling' case: Implications for pharma BD and investors
Daraxonrasib Pancreatic Cancer: What RevMed’s Breakthrough Means for Patients and Pharma
Biotech M&A Trends: Navigating the 2026 Outlook for Strategic Growth
Asia Surges as Biopharma Innovation Hub, Driving Global Drug Approvals
How AI Search is Transforming Pharma Marketing
Sedogen Receives U.S. Patent for Diazoxide Treatment of Prader-Willi Syndrome Behavioral Symptoms
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.